Psychopathology of addiction: May a SCL-90-based five dimensions structure be applied irrespectively of the involved drug? by Pani, Pp et al.
Pani et al. Ann Gen Psychiatry  (2016) 15:13 
DOI 10.1186/s12991-016-0100-8
PRIMARY RESEARCH
Psychopathology of addiction: May 
a SCL-90-based five dimensions structure be 
applied irrespectively of the involved drug?
Pier Paolo Pani1, Angelo G. I. Maremmani9,10, Emanuela Trogu4, Federica Vigna‑Taglianti2,3, Federica Mathis2, 
Roberto Diecidue2, Ursula Kirchmayer5, Laura Amato5, Joli Ghibaudi6, Antonella Camposeragna6, 
Alessio Saponaro7, Marina Davoli5, Fabrizio Faggiano8 and Icro Maremmani9,10,11*
Abstract 
Background: We previously found a five cluster of psychological symptoms in heroin use disorder (HUD) patients: 
‘worthlessness‑being trapped’, ‘somatic‑symptoms’, ‘sensitivity‑psychoticism’, ‘panic‑anxiety’, and ‘violence‑suicide’. We 
demonstrated that this aggregation is independent of the chosen treatment, of intoxication status and of the pres‑
ence of psychiatric problems.
Methods: 2314 Subjects, with alcohol, heroin or cocaine dependence were assigned to one of the five clusters. Dif‑
ferences between patients dependent on alcohol, heroin and cocaine in the frequency of the five clusters and in their 
severity were analysed. The association between the secondary abuse of alcohol and cocaine and the five clusters 
was also considered in the subsample of HUD patients.
Results: We confirmed a positive association of the ‘somatic symptoms’ dimension with the condition of heroin ver‑
sus cocaine dependence and of the ‘sensitivity‑psychoticism’ dimension with the condition of alcohol versus heroin 
dependence. ‘Somatic symptoms’ and ‘panic anxiety’ successfully discriminated between patients as being alcohol, 
heroin or cocaine dependents. Looking at the subsample of heroin dependents, no significant differences were 
observed.
Conclusions: The available evidence coming from our results, taken as a whole, seems to support the extension of 
the psychopathological structure previously observed in opioid addicts to the population of alcohol and cocaine 
dependents.
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Background
The relationship between substance use and other psy-
chiatric disorders is still an open question. According to 
the current nosographic approach, substance use disor-
ders are defined by the presence of the core symptoms 
of addiction, such as continuation of use despite con-
sequences, reduction of other interests and activities, 
craving, dyscontrol, and so on. Other distinctive psy-
chopathological symptoms of people with addictive 
behaviours are included in separate disorders pertain-
ing to the domain of psychiatric ‘comorbidity’. Several 
findings challenge this fragmentary approach to unitary 
clinical presentations and call for a revision of the pre-
sent nosology. Besides the high degree of association 
between core symptoms of addiction and symptoms of 
other psychiatric diseases [1–3], further neurobiological 
and clinical considerations highlight the strong sharing of 
features between addiction per se and other psychopath-
ological disorders, especially in the mood, anxiety and 
impulse/control domains [4]. On these bases, a unitary 
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perspective in the approach to patients with addiction, 
including psychological and psychiatric vulnerability, the 
effect of substances, the characteristics of addictive pro-
cesses, and their interactions has been proposed [4].
In view of the persistent uncertainty in classifying 
psychiatric symptomatology as intrinsic to the addic-
tive disorder or due to psychiatric comorbidity, a low 
level of inference on the psychopathology of addicted 
people has been applied recently, so that the symptoms 
expressed by patients are examined independently of 
a pre-established syndromic level [such as that of the 
Diagnostic and Statistical Manual of Mental Disorders 
(DSM)]. In a previous study that took this approach, 
we investigated the psychopathological dimensions of 
1055 heroin addicts entering opioid agonist treatment 
(OAT) [5]. By applying an exploratory principal com-
ponent factor analysis (PCA) to the 90 items on the 
SCL-90 checklist, a 5-factor solution was identified: 
the first factor reflected a depressive ‘worthlessness 
and being trapped’ dimension; the second factor picked 
out a “somatic symptoms” dimension; the third identi-
fied a ‘sensitivity-psychoticism’ dimension; the fourth a 
‘panic anxiety’ dimension; and the fifth a ‘violence-sui-
cide’ dimension. These same results were recently repli-
cated by applying the PCA to another Italian sample of 
1195 heroin addicts entering a Therapeutic Community 
Treatment [6]. Although this second sample differed 
from the first one in important sociodemographic and 
clinical factors, treatment setting, and programme char-
acteristics, the same five psychopathological dimen-
sions were found, suggesting the existence of specific 
clusters of psychological/psychiatric features within the 
category of opioid addicts.
Further analyses confirmed the clusters of symptoms, 
independently of demographic and clinical character-
istics, active heroin use, lifetime psychiatric problems, 
and kind of treatment received by the patient [6–8]. The 
available evidence, taken as a whole, seems to support the 
trait dependent, rather than the state dependent, nature 
of the proposed factorial dimensions of the psychopa-
thology of opioid addiction.
Our previous considerations on the nature of the 
relationship between addiction and other psychiatric 
domains, corroborated by neurobiological, epidemiologi-
cal, and clinical evidence do not apply to heroin depend-
ence only, but also to the other addictive disorders, which 
suggests that the investigation should be extended to 
other addictions.
The primary aim of the present study is to investi-
gate whether the five-factor psychic structure found in 
opioid dependents also applies to cocaine- or alcohol-
dependent patients. A secondary aim is to evaluate the 
impact of the use of other substances on the five cited 
psychopathological dimensions. On the basis of our 
unitary hypothesis, we expect that the use of other sub-
stances is likely to have
  • A pathoplastic effect on psychological/psychiat-
ric dimensions, related to the specific psychoactive 
properties of each substance;
  • No substantial effect on the five-dimension structure 
of psychopathology, as we believe this structure is 
intrinsic to the condition of addiction per se and is 
independent of the substance.
Methods
Study design and population
The VOECT (Evaluation of Therapeutic Community 
Treatments and Outcomes) cohort study was conducted 
in 8 Italian regions in 2008–2009, recruiting a total of 
2533 patients admitted to a Therapeutic Community 
(TC) treatment for a substance use disorder [9]. To ful-
fil the aims of the present analysis only baseline data 
were used, implementing a cross-sectional approach. 
Moreover, specific inclusion criteria were applied: at 
least 18 years old, with a diagnosis of heroin, cocaine or 
alcohol dependence based on a clinical judgement, and 
information available from the SCL-90 questionnaire. 
Reflecting these criteria, the sample consisted of 2314 
subjects. Each participant was included in the sample 
once only. Out of 2314 patients, 449 (19.4 %) were diag-
nosed as dependent on alcohol, 670 (28.9 %) on cocaine, 
and 1195 (51.6 %) on heroin.
The study was conducted according to the WMA 
Declaration of Helsinki—Ethical Principles for Medical 
Research Involving Human Subjects. All subjects exam-
ined filled up an informed consensus to participate in this 
study. Both the consent form and the experimental pro-
cedures were approved by the pertinent ethics commit-
tees in accordance with internationally accepted criteria 
for ethical research.
Instruments
Self‑report symptom inventory (SCL‑90)
Developed by Derogatis et al. [10], the SCL90 consists of 
90 items, each rated on a 5-point scale of distress. It is a 
self-report clinical rating scale oriented to the collection 
of symptomatic behaviours of psychiatric outpatients. 
Among heroin-dependent patients, the 90 items reflected 
the 5 primary symptom dimensions which are believed 
to underlie the large majority of symptom behaviours 
observed in this kind of patient: worthlessness-being 
trapped, somatic symptoms, sensitivity-psychoticism, 
panic-anxiety, and violence-suicide [5].
The worthlessness-being trapped dimension reflects 
a broad range of the symptoms typical of the clinical 
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depressive syndrome. This dimension mirrors feelings 
of worthlessness and of being trapped or caught. The 
somatic symptoms dimension reflects distress arising 
from perceptions of body dysfunctions. The sensitivity-
psychoticism dimension focuses on feelings of a full 
continuum of psychotic behaviours. The panic-anxiety 
dimension subsumes a set of symptoms and experiences 
usually clinically associated with a high level of manifest 
anxiety. The violence-suicide dimension is organized 
around three categories of hostile behaviour: thoughts, 
feelings, and actions; it also comprises thoughts of death 
and suicidal ideation.
In a previous study, these five dimensions were empiri-
cally established and validated [7, 8, 11, 12]. In the pre-
sent study, SCL-90 was administered to the patients 
within 15 days from the entry into TC.
Other instruments
Information on the sociodemographic and clinical char-
acteristics of the patients included in the study was col-
lected through a research questionnaire administered 
at the time of entering TC. The secondary substance of 
abuse (one or more) was self-reported by the patient.
Data analysis
Two analysis sets were obtained. The principal analy-
sis was run on the full sample of subjects entering TC 
treatment for opioid, cocaine, or alcohol dependence 
(n  =  2314); this sample was divided into three groups 
according to the primary substance of abuse. The sec-
ondary analysis was performed on subjects entering a TC 
treatment for opioid dependence. Only opioid addicts 
reporting cocaine, alcohol, or neither of these as second-
ary substances of abuse were included (n =  947), while 
those reporting both as secondary substances of abuse 
were excluded. Patients were compared as regards demo-
graphic and clinical variables by means of the Chi-square 
test (with Bonferroni’s correction) for categorical vari-
ables, and Student’s t test for continuous variables.
SCL-90 factors were standardized into z-scores in order 
to make scores comparable. Each subject was assigned 
to one of the five subtypes on the basis of the highest 
z-score achieved (named “dominant SCL-90 factor”). 
This procedure gives the opportunity to classify subjects 
on the basis of the highest symptomatological cluster, 
overcoming the problem of identifying a cut-off point for 
the inclusion of patients in the clusters. The subtypes are 
clearly distinct, as shown by analysing the mean z-scores 
and 95 % confidence interval (CI 95 %) across the factors 
for each dominant group [5]. Psychopathological symp-
toms were then compared by means of the Chi-square 
test, with Bonferroni’s correction, between patients with 
primary dependence on alcohol, heroin, or cocaine; and 
between patients with primary dependence on opioids 
and secondary use of cocaine, alcohol, or neither of these 
substances.
Stepwise multinomial logistic regression analysis was 
then conducted with the primary substance of abuse 
(heroin, cocaine, or alcohol) as dependent variable and 
the psychopathological dominant groups as predictors. 
In our model, we included sociodemographic and clinical 
variables that may act as confounding factors (age, gen-
der, marital status, detoxification status, living condition). 
A second logistic regression investigating cocaine ver-
sus alcohol as primary substance of abuse and including 
the same sociodemographic and clinical variables as had 
been used in the previous model as possible confounders 
was also carried out.
SCL-90 5-factor solution scores were compared on the 
base of the primary or secondary abused substance at 
univariate (t test) and multivariate (discriminant analysis) 
level. Discriminant analysis is useful to statistically distin-
guish between two or more groups of cases, and is also a 
powerful classification technique. By classifying the cases 
used to derive the functions, and comparing predicted 
group membership with actual group membership, one 
can empirically measure the success in discrimination by 
observing the proportion of correct classifications. The 
purpose is to see how effective the discriminating vari-
ables are. If a large proportion of misclassification occurs, 
then the selected variables are poor discriminators. We 
used the stepwise procedure to select the best discrimi-
nating variables.
All analyses were carried out using SPSS v. 4.0 (SPSS, 
Chicago, IL, USA). Statistical significance was set at the 
p = 0.05 level.
Results
Sociodemographic and addiction characteristics
In the overall sample (n  =  2314), mean age was 
35.2 ± 8.5 years, 84.2 % of the subjects were male, 87.9 % 
were single, separated, divorced, or a widow(er), 20.5  % 
had a high educational level (with duration over 8 years), 
79.1  % of subjects were unemployed, and 26.5  % lived 
alone.
When looking at differences between alcohol, heroin 
and cocaine patients, mean age was 41.4  ±  8.8 among 
alcohol-dependent, 33.8  ±  7.7 among heroin-depend-
ent, and 33.6 ±  7.7 among cocaine-dependent patients. 
This difference was statistically significant (F  =  168.87; 
p = 0.000). As regards gender, the frequency of males was 
85.2 % among patients with alcohol dependence, 81.4 % 
among those with heroin dependence, and 88.7 % among 
those with cocaine dependence (Chi-square  =  17.30; 
p = 0.000). The frequency of single/separated/divorced/
widow(er) subjects was 87.5, 90.2 and 84.1  % among 
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alcohol-, heroin-, and cocaine-dependent patients, 
respectively (Chi-square  =  14.88; p  =  0.001). Educa-
tional level was high (covering over 8  years) in 20.5  % 
of the alcohol sample, 21.5 % of the heroin sample, and 
18.7  % of the cocaine sample, without statistically sig-
nificant differences between groups (Chi-square 2.1; 
p = 0.366). 77.7 % of patients with alcohol dependence, 
79.8  % of those with heroin dependence, and 78.8  % of 
those with cocaine dependence were unemployed (Chi-
square = 0.95; p = 0.621). 37.5, 24.1, and 23.4 % for the 
alcohol, heroin, and cocaine group of patients, respec-
tively, were living alone (chi = 23.71; p = 0.000).
Among patients with opioid dependence (n  =  1195), 
mean age was 34.45 ±  7.1 for the group with alcohol as 
secondary substance of abuse, 33.64 ± 7.5 for those with 
cocaine, and 35.61 ±  7.6 for those with neither of these 
substances as secondary substance of abuse (F  =  2.91; 
p  =  0.055). The frequency of males was 78.5  % among 
patients who used alcohol as secondary substance of abuse, 
82.9 % among those who used cocaine, and 76.5 % among 
those who used neither of the two (Chi-square  =  2.83; 
p = 0.243). The frequency of subjects who were single, sep-
arated, divorced, or a widow(er), was 88.6, 90.9, and 84.7 %, 
respectively (Chi-square =  3.53; p =  0.170). Educational 
level was high (covering over 8  years) in 31.6  % of those 
whose secondary substance of abuse was alcohol, 19.5  % 
with cocaine, and 28.2 % of the patients using neither as 
secondary substance (Chi-square  =  9.06; p  =  0.011). 
81.0  % of patients whose secondary substance of abuse 
was alcohol, 82.5 % of those using cocaine, and 65.9 % of 
those using neither as secondary substance were unem-
ployed (Chi-square = 13.65; p = 0.001). The percentages 
for those living alone were 32.9, 24.4, and 19.3 % for those 
using alcohol, cocaine, or neither of the two as secondary 
substance of abuse, respectively (chi = 4.08; p = 0.130).
Psychopathological dimensions
Table  1 shows differences in psychopathological symp-
toms between patients with addiction to alcohol, her-
oin, or cocaine as primary substance of abuse. The most 
frequent psychopathological dimension was ‘panic-
anxiety’ for all the three groups of patients. The least 
frequent psychopathological dimensions were ‘violence-
suicide’ for the group of patients with alcohol depend-
ence (11.4  %) and ‘worthlessness-being trapped’ for the 
patients with heroin or cocaine dependence (15.1 and 
16.0 %, respectively).
The only statistically significant differences observed 
between the three groups were in the frequency of
  • The ‘somatic symptoms’ dimension, which was better 
represented in the group of patients with heroin than 
in the group with cocaine dependence;
  • ‘Sensitivity-psychoticism’, which was more frequent 
in the group of patients with alcohol than in the 
group with heroin dependence;
  • The ‘violence-suicide’ dimension, which had a higher 
frequency in the groups of patients with heroin or 
cocaine than in the group with alcohol dependence.
The multinomial logistic regression confirmed a sig-
nificant positive association of the ‘somatic-symptoms’ 
dimension with the heroin versus the cocaine group and 
of the ‘sensitivity-psychoticism’ dimension with the alco-
hol versus the heroin group (Table 2). The further logistic 
regression investigating cocaine versus alcohol as pri-
mary substance of abuse did not detect any significant 
association between the five SCL 90 dominant groups 
and the primary substance of abuse.
Table 3 shows differences in psychopathological symp-
toms between patients with opioid dependence and 
secondary abuse of alcohol, or else cocaine or neither 
of these drugs. The most frequent psychopathological 
dimension was ‘panic-anxiety’ for all the three groups 
of patients The less frequent were ‘violence-suicide’ and 
‘sensitivity-psychoticism’ for the group of patients with 
alcohol as secondary abused drug, ‘violence-suicide’ for 
the group of patients with no alcohol or cocaine as sec-
ondary drug, and ‘worthlessness-being trapped’ for the 
group of patients with cocaine as secondary abused drug. 
No statistically significant differences between the three 
groups were observed in any of the five SCL-based psy-
chopathological dimensions.
With reference to psychopathological severity, Table 4 
shows the results of the univariate and multivariate (step-
wise discriminant) analysis comparing patients with 
dependence on alcohol, heroin, or cocaine. All SCL-90 
dimensions, with the exception of ‘violence-suicide’, were 
Table 1 SCL90-based predominant psychopathological 
symptoms according to  the primary substance of  abuse 
at treatment entry
Chi square 28.61; df 8; p < 0.001
Each letter denotes a subset of categories whose column proportions do not 
differ significantly from each other at the 0.05 level
Dominant  
group
Total
N = 2314
Alcohol
N = 449
Heroin
N = 1195
Cocaine
N = 670
N (%) N (%) N (%)
1. Worthlessness‑
being trapped
349 (15.1) 62 (13.8)a 180 (15.1)a 107 (16.0)a
2. Somatic  
symptoms
509 (22.0) 102 (22.7)a,b 291 (24.4)b 116 (17.3)a
3. Sensitivity‑ 
psychoticism
465 (20.1) 110 (24.5)a 218 (18.2)b 137 (20.4)a,b
4. Panic‑anxiety 605 (26.1) 124 (27.6)a 300 (25.1)a 181 (27.0)a
5. Violence‑suicide 386 (16.7) 51 (11.4)a 206 (17.2)b 129 (19.3)b
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higher in the group of patients with alcohol dependence 
than in the group with heroin dependence, and in this 
second group than in the group of patients with cocaine 
dependence. Scores for the ‘violence-suicide’ dimension 
were higher in patients with cocaine dependence or her-
oin dependence than in those with alcohol dependence. 
Statistically significant differences were found for
  • ‘Somatic symptoms’, where patients with alcohol 
or heroin dependence showed higher scores than 
patients with cocaine dependence;
  • ‘Panic-anxiety, where patients with alcohol depend-
ence showed higher scores than patients with cocaine 
or heroin dependence.
The stepwise analysis identified the severity of ‘somatic 
symptoms’ and ‘panic anxiety’ as the factors best discrim-
inating between the three groups of patients. However, 
according to this analysis, the percentage of the origi-
nally grouped cases correctly classified is only 35.7  %. 
The other SCL-90-based psychopathological dimensions 
were unable to improve the value of the discrimination.
Looking at the 5-factor solution SCL-90 scores, Table 5 
shows univariate and multivariate (stepwise discrimi-
nant) analysis for the sample of patients with opioid 
dependence and secondary abuse of alcohol, cocaine, 
or neither of these drugs. All the SCL-90 dimensions 
were higher in patients who were co-abusing alcohol 
or cocaine compared with those not adding these other 
drugs. In any case, none of the differences observed 
reached statistical significance and none of the five psy-
chopathological dimensions showed a discriminant 
value.
Discussion
Patients with alcohol, heroin, or cocaine dependence 
differ in most of the demographic characteristics inves-
tigated in our study. Differences were observed in age, 
frequency of male gender, marital status, and living con-
ditions. Alcohol dependents were older and a higher 
percentage of these subjects lived alone than in the case 
of heroin or cocaine dependents; heroin dependents 
were less frequently male and more frequently single 
than cocaine-dependent patients. In patients with pri-
mary opioid dependence, those with cocaine as second-
ary substance of abuse had received less education than 
those with alcohol as secondary substance of abuse and 
they were more frequently unemployed than those who 
had no secondary substance of abuse. These differences 
are consistent with the sociodemographic characteristics 
of the diverse populations of addicts reported in previous 
studies [13–15].
Looking now at the predominant psychopathologi-
cal symptoms of the full sample of patients according to 
the primary substance of abuse at treatment entry, few 
significant differences were found. Taking into account 
sociodemographic and clinical confounding factors, 
the only significant difference was found in the ‘somatic 
symptoms’ dimension, which had a higher frequency 
in the heroin versus the cocaine group of patients and 
in the ‘sensitivity-psychotic’ dimension, which was 
Table 2 Risk factors for  alcohol or cocaine versus  heroin 
dependence at  treatment entry, according to  logistic 
regression (only significant results are reported), 2314 
patients
Statistics: Chi-square 375.88; df 20; p < 001
This table includes SCL-90 factors as exposure variables, other demographic 
and clinical variables as possible confounders, and primary substance of abuse 
(alcohol or cocaine vs. heroin) as a dependent variable
a Considering heroin as reference primary substance of abuse
b Considering prominent worthlessness-being trapped symptoms as reference 
psychopathology
Primary substance of abusea B Odds  
ratio
95 % CI p
Alcohol
 Age 0.11 1.11 1.09–1.13 0.000
 Living alone 0.32 1.38 1.06–1.80 0.017
 Detoxified status 0.61 1.84 1.44–2.35 0.000
 SCL90 dominant groups
  Prominent sensitivity‑ 
psychoticismb
0.43 1.54 1.02–2.32 0.039
Cocaine
 Male gender 0.53 1.70 1.27–2.27 0.000
 Single marital status −0.53 0.59 0.43–0.80 0.001
 Detoxified status 0.45 1.57 1.29–1.92 0.000
 SCL90 dominant groups
  Prominent somatic  
symptomsb
−0.39 0.68 0.48–0.95 0.023
Table 3 SCL90-based predominant psychopathologi-
cal symptoms in  heroin-dependent patients according 
to their secondary substance of abuse
Chi-square = 5.38; df = 8; p = 0.715
Post-hoc test (Bonferroni’s procedure): no differences
SCL90-based factors Secondary substance of abuse
Alcohol
N = 79
Cocaine
N = 783
Neither alcohol 
nor cocaine
N = 85
N (%) N (%) N (%)
1. Worthlessness‑being 
trapped
15 (19.0) 113 (14.4) 12 (14.1)
2. Somatic symptoms 17 (21.5) 191 (24.4) 18 (21.2)
3. Sensitivity‑ 
psychoticism
14 (17.7) 138 (17.6) 20 (23.5)
4. Panic‑anxiety 19 (24.1) 199 (25.4) 25 (29.4)
5. Violence‑suicide 14 (17.7) 142 (18.1) 10 (11.8)
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more frequent in the alcohol versus the heroin group of 
patients. The higher allocation of heroin-dependent ver-
sus cocaine-dependent patients to the ‘somatic symp-
toms’ group may be explained by the pre-eminence of 
the withdrawal symptomatology in the everyday life of 
heroin-dependent as opposed to cocaine-dependent 
patients [5, 16]. The higher allocation of patients depend-
ent on alcohol versus those dependent on heroin to the 
‘sensitivity-psychotic’ dimension may be explained by 
the pre-eminence of the psychotic component of alcohol 
withdrawal as well as by the likely association of alco-
hol dependence, when compared with heroin depend-
ence, including the presence of overt psychotic disorders 
[17–22].
Turning now to the frequency of the five predominant 
psychopathological dimensions in patients with primary 
opioid dependence, the use of alcohol or cocaine as 
secondary substance of abuse does not lead to any sig-
nificant difference; thus the use of these additional sub-
stances appears to have no impact on these dimensions.
As regards psychiatric severity, considering the full 
sample, the SCL-90 average scores seem to follow a 
decreasing order in four of the five psychopathologi-
cal dimensions, with patients who have primary alcohol 
dependence showing the highest and those with cocaine 
dependence the lowest severity. However, significant dif-
ferences between the three groups were observed for 
the ‘somatic symptoms’ and the ‘panic-anxiety’ dimen-
sions only, with alcohol or heroin dependence associated 
with higher scores for ‘somatic symptoms’ than in the 
case of cocaine dependence, and with alcohol depend-
ence associated with higher scores for the ‘panic-anxiety’ 
dimension than in the case of cocaine dependence. Con-
sistently with the foregoing, when discriminant analysis 
was applied, these two dimensions were the only factors 
that were able to distinguish between substance-defined 
groups of patients, although the discriminant power of 
these dimensions was rather weak, with only 35.7  % of 
these cases, as originally grouped, proving to be correctly 
classified.
Table 4 SCL90-based psychopathological factor severity in  2314 drug addicts according to  the primary substance 
of abuse at treatment entry
Wilks Lambda 0.97; Chi-square 55.70; df 10; p < 0.001
Correctly classified: 35.7 %
Each letter denotes a subset of categories whose column proportions do not differ significantly from each other at the 0.05 level
a Discriminant function (structured matrix)
Variables Alcohol
N = 449
Heroin
N = 1195
Cocaine
N = 670
Univariate
F; df; p
dfa
M ± SD M ± SD M ± SD
1. Worthlessness‑being trapped 1.17 ± 0.7 1.14 ± 0.8 1.11 ± 0.7 0.73; 2; 0.481 0.16
2. Somatic‑symptoms 1.02 ± 0.7a 1.00 ± 0.7a 0.88 ± 0.7b 7.21; 2; 0.001 0.52
3. Sensitivity‑psychoticism 0.82 ± 0.6 0.77 ± 0.6 0.76 ± 0.6 1.10; 2; 0.330 0.17
4. Panic‑anxiety 0.47 ± 0.5a 0.43 ± 0.6a,b 0.38 ± 0.5b 3.72; 2; 0.024 0.38
5. Violence‑suicide 0.75 ± 0.6 0.79 ± 0.7 0.80 ± 0.7 0.85; 2; 0.425 −0.16
Centroids 0.191 0.047 −0.211
Table 5 SCL90-based psychopathological factor severity in  heroin use disorder according to  the secondary substance 
of abuse
Post-hoc test (Scheffe’s procedure): no differences between groups in any psychopathological factor
Discriminant analysis
FD1 Wilks lambda = 0.98; Chi-square = 13.28; df 10, p = 0.208
FD2 Wilks lambda = 0.99; Chi-square = 1.26; df 4, p = 0.867
SCL90-based factors Heroin + alcohol
N = 79
Heroin + cocaine
N = 783
Heroin (neither  
alcohol nor cocaine)
N = 85
F p
M ± SD M ± SD M ± SD
1. Worthlessness‑being trapped 1.13 ± 0.7 1.15 ± 0.8 1.02 ± 0.8 1.01 0.362
2. Somatic symptoms 0.99 ± 0.7 1.02 ± 0.7 0.91 ± 0.7 0.81 0.444
3. Sensitivity‑psychoticism 0.70 ± 0.5 0.81 ± 0.7 0.66 ± 0.6 2.28 0.102
4. Panic‑anxiety 0.41 ± 0.5 0.45 ± 0.6 0.34 ± 0.5 1.30 0.271
5. Violence‑suicide 0.69 ± 0.5 0.83 ± 0.7 0.64 ± 0.6 3.72 0.024
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The discriminating feature of the ‘somatic symptoms’ 
dimension may be explained by the higher burden of 
physical concerns that accompanies heroin or alcohol 
dependence, compared with dependence on cocaine, 
especially when considering the importance of with-
drawal-related physical symptoms in heroin and alcohol 
dependence. Indeed, the SCL-90 items included in the 
‘somatic-symptoms’ dimension correspond to a number 
of complaints (in particular, muscle aches, back pain, hot 
flushes and cold shivers, nausea, and disturbed sleep) 
which are usually prominent in opioid or alcohol with-
drawal [5, 16]. Conversely, in cocaine dependence, with-
drawal is frequently associated with mild or no somatic 
symptoms.
It appears to be more difficult to explain the higher 
severity induced by alcohol dependence than by cocaine 
dependence with reference to the ‘panic-anxiety’ dimen-
sion. Both forms of dependence, on alcohol and on 
cocaine, have been associated with a strikingly high odds 
ratio for the presence of anxiety disorders, and anxi-
ety has been identified as a determinant of the progres-
sion from use of substances to dependence [1, 23, 24]. 
However, anxiety is a common symptom of the effects 
of cocaine and of cocaine intoxication, whereas in alco-
hol, dependence symptoms of the anxiety spectrum 
are expressed instead as a component of withdrawal 
where, even in mild forms of alcohol dependence, anxi-
ety appears as an essential element. Moreover, we have 
also to take into account that alcohol withdrawal-related 
anxiety, unlike most of the other physical symptoms 
accompanying withdrawal, may last for months [25, 
26]. Persistent changes in the GABA and NMDA cir-
cuits associated with tolerance and withdrawal may sup-
port the persistence of anxiety-related symptoms [27, 
28]. Therefore, the highest scores observed in patients 
belonging to the alcohol-dependents group, as well as the 
contribution of the ‘panic-anxiety’ dimension to the dis-
crimination between dependence to different substances, 
may reflect the weight of withdrawal-related anxiety in 
the everyday life of patients affected by different forms of 
drug addiction.
Looking at the analyses carried out with heroin-
dependent patients only, no difference was shown on the 
basis of the use of alcohol or cocaine as secondary sub-
stance of abuse, either in the frequency of the five psy-
chopathological dimensions or in the severity of SCL-90 
scores.
Considering as a whole the results obtained by our 
study, it seems that when the five-factor SCL-based 
cluster of symptoms obtained with a population of her-
oin-dependent patients is compared with a different 
population of cocaine or alcohol dependents, only slight 
differences are observed, a result that can be explained 
by the impact of different substances on specific psy-
chological/psychiatric dimensions. One of these dimen-
sions—somatic symptoms—proved to be the strongest 
discriminating factor between the three populations con-
sidered. Even so, the best discriminating solution, which 
also included the panic-anxiety dimension, was only able 
to correctly classify 35.7  % of cases. This low discrimi-
nating power of the five SCL-90-based dimensions may 
be attributed to a psychopathological structure of drug 
addiction that is shared by the various forms of depend-
ence, so that the structure is largely independent of the 
specific drug used; this result allows to define addiction 
as a unitary condition.
Limitations
In this study, we have found evidence of the similar-
ity of the SCL-90-based five-factor psychopathological 
structure in the three cases of heroin, cocaine, and alco-
hol dependence, but, given the cross-sectional design 
of the study, we still do not know whether the previous 
presence and severity of symptoms included in the five 
psychopathological dimensions may be a predictor of 
or predispose to dependence on specific substances, or 
whether, conversely, the use of, or dependence on these 
substances may condition the appearance of the spe-
cific psychopathological picture. Moreover, although 
we did take into account sociodemographic and clinical 
variables as confounding factors, other primary potential 
interfering factors, such as formal psychiatric diagnoses, 
were unavailable and could not be taken into account.
Other limits to the validity of the SCL-90-based psy-
chopathological 5-dimension solution were commented 
on in our previous studies on the SCL-90 defined struc-
ture of the psychopathology of opioid addiction [5, 8, 11]. 
Among these, there is the lack of any observer-related 
‘objective’ evaluation, as SCL-90 is a self-administered 
instrument that may be affected by the voluntary or 
involuntary hiding of some symptoms.
Lastly, a further limitation is that in this analysis we 
considered only the SCL-90 questionnaire that was 
administered at entry into treatment, so our results can 
only be considered to be representative of subjects who 
had an addiction at that particular moment. Some symp-
toms may vary at different stages of the disease, so that 
they may prove to be underweighted or overweighted in 
our sample.
Conclusions
In our study, the frequencies of the five clusters of 
symptoms resulting from the application of PCA to 
the SCL-90 responses of opioid addicts turn out to dif-
fer, in a statistically significant way, only in the case of 
the ‘somatic symptoms’ dimension between cocaine 
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and opioid-dependent patients and with the ‘sensitivity-
psychoticism’ dimension between alcohol- and opioid-
dependent subjects. Moreover, the ‘somatic symptoms’ 
and ‘panic-anxiety’ dimensions seem to be the only 
psychopathologically discriminant factors between the 
three populations. Looking only at the population of opi-
oid addicts, no differences in the psychic structure were 
shown on the basis of the co-abuse of alcohol or cocaine.
These findings should be added to those of previous 
studies that had shown the considerable stability of the 
five-factor structure of opioid addiction. At the same 
time, our latest results support its extension to the popu-
lation of alcohol and cocaine dependents, where the role 
played by the different substances seems to be that of 
having a pathoplastic effect on some specific dimensions, 
without substantially interfering with the proposed five-
dimension structure, since this structure belongs to the 
condition of addiction per se and is independent of the 
various substances considered.
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